Biodefense start-up companies have an abundance of options when seeking funding.
Sandy Weinberg, PhD
Advertisement
Sandy Weinberg, PhD, is an associate professor of healthcare management at Clayton State University
Articles by Sandy Weinberg, PhD
Advertisement
Latest Updated Articles
Funding Biodefense Vaccine DevelopmentPublished: April 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
